Patients were classified as low-risk or high-risk according to neutropenia duration (greater or less than 7 days), hepatic or renal dysfunction, and ANC count. Throughout the study period, 115 ...

Among patients with pancreatic cancer being treated with modified FOLFIRINOX, those who develop severe neutropenia have significantly longer median overall survival, as well as longer time to ...

Neutropenia is a hematological disorder defined as a reduction in the absolute number of neutrophils in the blood. The most common causes of neutropenia are those that are acquired, including viral ...

The American Society of Clinical Oncology (ASCO) has bulked up its advice to clinicians about managing patients who undergo chemotherapy. The organization has issued a new guideline on how and when to ...

Neutrophilic granulocytes, which are otherwise known as neutrophils or polymorphonuclear (PMN) leukocytes, are the most abundant circulating white blood cells in humans. Thus, neutrophils play a ...

The frequency of neutropenia in patients receiving long-term cefepime therapy for osteomyelitis compared with that in patients receiving other antimicrobials was studied. A comparative case review was ...

Please provide your email address to receive an email when new articles are posted on . In a comparison study of abatacept, infliximab and tocilizumab for the treatment of 499 patients with rheumatic ...

Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...

Chemotherapy-induced neutropenia is a complication of cancer treatment that has many consequences for the patient. The incidence of death from neutropenic fevers and sepsis is estimated to be about 5% ...

To evaluate the incidence, onset, duration, characteristics and importance of late-onset neutropenia (defined as absolute neutrophil count<1500 μl −1 at 3 weeks of age or later) in a group of very low ...